careprost : Try For Darker and Thicker Eyelashes

Careprost 0.03%, and 0.01% are two performances marketed in the USA, UK, and all over the globe that corresponds to Lumigan. They differ in the concentration of active components present in eye drops, although they have the same efficacy by comparing with other ingredients included in the formula. Your ophthalmologist will indicate the most suitable for you.

On the other hand, Bimatoprost online and Super Lash RC is equivalent to Bimatoprost 0.01% that is currently not sold in the USA, UK.

Careprost Eye Drops is a drug intended to treat ocular hypertension and glaucoma. Like any drug applied to the eye, it tends to produce an inevitable transient blur but does not permanently impair vision.

Reduction of elevated intraocular pressure in adult patients with chronic open-angle glaucoma or intraocular hypertonia (as monotherapy or in combination with beta-blockers).

Conditions for which this medication may be prescribed

• Chronic open-angle glaucoma
• Intraocular hypertonia

Dosage

The suggested dosage is one drop in the affected eye (s) once a day, administered in the evening. The dose should not exceed one installation per day; more regular use may decrease the effectiveness of the drop in intraocular pressure.

Pediatric population

The safety and efficacy of Buy Careprost and Bimat in children aged 0-18 years have not yet been established.

Patients with hepatic or renal impairment

Bimatoprost has not been studied in patients with renal impairment or moderate to severe hepatic impairment. Therefore, it should be used with caution in these patients. In patients with a history of mild liver disease or abnormal baseline levels of alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), and bilirubin, no harmful effects on liver function have been observed with eye drops containing 0.3 mg/ml bimatoprost over 24 months.

Administration mode

In case of concomitant use of several ophthalmic drugs for local disease, an interval of at least 5 minutes must be respected between the administrations of each of them.

Possible side effects of the drug Careprost

• cephalalgia
• Dizzying feeling
• Conjunctival hyperemia
• Superficial punctate keratitis
• Eye irritation
• Eye pruritus
• Eyelash growth
• Eye pain

Itching of the eyelid

• Erythema of the eyelid
• asthenopia
• Visual disturbance
• Conjunctival disorders
• In the 12-month phase III clinical study, about 38% of patients treated with Bimatoprost 0.1 mg/ml encountered side effects. The most common side effect was conjunctival hyperemia occurring in 29% of patients; most of the time, hyperemia was minimal to mild and non-inflammatory. About 4% of patients discontinued treatment due to side effects.
• The side effects described below have been reported through clinical trials with careprost 0.1 mg/ml, eye drops in solution, or after it has been marketed. Most were ocular, of mild intensity, and none were severe.
• eyelash growth up to 45% in the first year with an incidence of new cases reduced to 7% at two years and 2% at three years, conjunctival hyperemia (mostly minimal to mild and considered to be non-inflammatory) up to 44% of patients in the first year with an incidence of new cases reduced to 13% at two years and 12% at three years.
• eye pruritus in up to 14% of patients in the first year with an incidence of new cases reduced to 3% at two years and 0% at three years. Less than 9% of patients had to discontinue treatment due to an adverse event in the first year, with an incidence of additional discontinuations of 3% in the second and third years.

Other side effects reported with genuine careprost and Careprost eyelash serum 0.3 mg/ml are presented in Table 2. This table also includes side effects that occurred with the two formulations, but with various frequencies. Most of these effects are ocular, mild to moderate, and none have been severe: for each rate, the unwanted effects are presented in decreasing order of severity.